Peter Doyle
Keine laufenden Positionen mehr
Profil
Peter Doyle has been a Director of Syngenta AG since 2000.
He is a Non-Executive Director of Avidex Ltd.
He was Chairman of the Biotechnology and Bioscience Research Council from 1989 to 2003 and a Non-Executive Director of Oxagen from 1999 to 2002 and Oxford Molecular Plc from 1997 to 2000.
He was a Director of Zeneca Group Plc from 1993 to 1999 and ICI from 1989 to 1993.
He is a Member of the Advisory Board of Vida Capital Partners and a Trustee of the Nuffield Foundation and Past Master of the Salters' Livery Company.
He received a BS and a PhD in Chemistry from Glasgow University.
Ehemalige bekannte Positionen von Peter Doyle
| Unternehmen | Position | Ende |
|---|---|---|
| SYNGENTA | Corporate Officer/Principal | 01.04.2009 |
Avidex Ltd.
 Avidex Ltd. Pharmaceuticals: MajorHealth Technology Avidex Ltd. develops and discovers drugs for the treatment of cancer and autoimmune diseases. The company develops small molecule and protein therapeutics involving T cell receptors. Avidex was founded in 1999 and is headquartered in Abingdon, UK | Direktor/Vorstandsmitglied | 04.12.2008 |
Oxagen Ltd.
 Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | 01.01.2002 |
| Oxford Molecular Group Plc | Direktor/Vorstandsmitglied | 01.01.2000 |
Zeneca Group Plc
 Zeneca Group Plc Pharmaceuticals: MajorHealth Technology Zeneca Group Plc used to develop & manufacture pharmaceutical products, agrochemicals and specialties chemicals. Its agrochemicals products include herbicides, insecticides and fungicides. The firm products were used by health care, agrochemical, paint, leather and imaging applications industries. The company was headquartered in London, UK. | Direktor/Vorstandsmitglied | 01.01.1999 |
Ausbildung von Peter Doyle
| University of Glasgow | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Imperial Chemical Industries Ltd.
 Imperial Chemical Industries Ltd. Chemicals: Major DiversifiedProcess Industries Imperial Chemical Industries Ltd. manufactures chemicals and paint products. Its products include coatings, adhesives, starch, and synthetic polymer. The company was founded on December 7, 1926 and is headquartered in Slough, the United Kingdom. | Process Industries |
Syngenta AG
 Syngenta AG Chemicals: AgriculturalProcess Industries Syngenta AG specializes in crop protection and seeds production. Its products include selective and non-selective herbicides, fungicides, insecticides, as well as field crop and vegetable seeds. The company was founded on November 12, 1999 and is headquartered in Basel, Switzerland. | Process Industries |
| Oxford Molecular Group Plc | Health Technology |
Oxagen Ltd.
Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom. | Health Technology |
Zeneca Group Plc
Zeneca Group Plc Pharmaceuticals: MajorHealth Technology Zeneca Group Plc used to develop & manufacture pharmaceutical products, agrochemicals and specialties chemicals. Its agrochemicals products include herbicides, insecticides and fungicides. The firm products were used by health care, agrochemical, paint, leather and imaging applications industries. The company was headquartered in London, UK. | Health Technology |
Avidex Ltd.
Avidex Ltd. Pharmaceuticals: MajorHealth Technology Avidex Ltd. develops and discovers drugs for the treatment of cancer and autoimmune diseases. The company develops small molecule and protein therapeutics involving T cell receptors. Avidex was founded in 1999 and is headquartered in Abingdon, UK | Health Technology |